dual gip and glp-1 receptor agonist Understand GLP-1/GIP Tirzepatide Its Effect on Current Weight Loss Therapy GLP-1/GIP Dual Receptor Agonist -
Description
49 GLP-1RAs represent a pharmacotherapeutic category of injectable hypoglycemic agents that are sanctioned as adjunctive therapies to diet and exercise for the management of type 2 diabetes mellitus (T2DM) in adult patients and potentially hold promise in addressing other medical conditions

doi: Disclaimer: This website does not provide medical advice
Wadden TA, Brown GK, Egebjerg C, Frenkel O, Goldman B, Kushner RF, et al

Triple agonists take this strategy further by targeting GLP-1R, GIPR, and the glucagon receptor (GCGR), aiming to regulate multiple complementary metabolic pathways
